Suppr超能文献

心脏康复在降低心脏移植患者主要不良心脏事件中的作用。

The Role of Cardiac Rehabilitation in Reducing Major Adverse Cardiac Events in Heart Transplant Patients.

机构信息

School of Kinesiology, University of Minnesota, Minneapolis, MN 55455, USA.

Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Card Fail. 2020 Aug;26(8):645-651. doi: 10.1016/j.cardfail.2020.01.011. Epub 2020 Jan 23.

Abstract

BACKGROUND

Methods for reducing major adverse cardiac events (MACE) in patients after heart transplantation (HTx) are critical for long-term quality outcomes.

METHODS AND RESULTS

Patients with cardiopulmonary exercise testing prior to HTx and at least 1 session of cardiac rehabilitation (CR) after HTx were included. Exercise sessions were evaluated as ≥ 23 or < 23 sessions based on recursive partitioning. We included 140 patients who had undergone HTx (women: n = 41 (29%), age: 52 ± 12 years, body mass index: 27 ± 5 kg/m). Mean follow-up was 4.1 ± 2.7 years, and 44 patients (31%) had a MACE: stroke (n = 1), percutaneous intervention (n = 5), heart failure (n = 6), myocardial infarction (n = 1), rejection (n = 16), or death (n = 15). CR was a significant predictor of MACE, with ≥ 23 sessions associated with a ∼ 60% reduction in MACE risk (hazard ratio [HR]: 0.42, 95% CI: 0.19-0.94, P = 0.035). This remained after adjusting for age, sex and history of diabetes (HR: 0.41, 95% CI: 0.18-0.94, P = 0.035) as well as body mass index and pre-HTx peak oxygen consumption (HR: 0.40, 95% CI: 0.18-0.92, P = 0.031).

CONCLUSIONS

After adjustment for covariates of age, sex, diabetes, body mass index, and pre-HTx peak oxygen consumption, CR attendance of ≥ 23 exercise sessions was predictive of lower MACE risk following HTx. In post-HTx patients, CR was associated with MACE prevention and should be viewed as a critical tool in post-HTx treatment strategies.

摘要

背景

对于心脏移植(HTx)后患者的重大不良心脏事件(MACE)的降低方法,对长期质量结果至关重要。

方法和结果

纳入了在 HTx 前进行心肺运动测试且在 HTx 后至少进行 1 次心脏康复(CR)的患者。根据递归分区,将运动次数评估为≥23 次或<23 次。我们纳入了 140 名接受 HTx 的患者(女性:n=41(29%),年龄:52±12 岁,体重指数:27±5 kg/m)。平均随访时间为 4.1±2.7 年,有 44 名患者(31%)发生 MACE:中风(n=1),经皮介入(n=5),心力衰竭(n=6),心肌梗死(n=1),排斥(n=16)或死亡(n=15)。CR 是 MACE 的显著预测因素,≥23 次的 CR 与 MACE 风险降低约 60%相关(风险比 [HR]:0.42,95%置信区间:0.19-0.94,P=0.035)。在调整年龄、性别和糖尿病史(HR:0.41,95%置信区间:0.18-0.94,P=0.035)以及体重指数和 HTx 前峰值摄氧量(HR:0.40,95%置信区间:0.18-0.92,P=0.031)后,这一结果仍然存在。

结论

在调整年龄、性别、糖尿病、体重指数和 HTx 前峰值摄氧量等协变量后,接受≥23 次 CR 的患者预测 HTx 后发生 MACE 的风险较低。在 HTx 后患者中,CR 与 MACE 的预防有关,应将其视为 HTx 后治疗策略的重要工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验